Stockreport

Is Summit Therapeutics (SMMT) Still Attractive After Recent Pullback And Multi Year Surge [Yahoo! Finance]

Summit Therapeutics Inc.  (SMMT) 
Last summit therapeutics inc. earnings: 6/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: summitplc.com/investors/investor-centre
PDF The stock is trading at US$17.04, with a 1 year return of 2.3% and a very large 3 year gain that is around 3x, even after an 8.7% decline over the last week and a 3.0% [Read more]